Amplify Weight Loss Drug & Treatment ETF (THNR) Institutional Ownership $23.23 +0.14 (+0.61%) As of 02/21/2025 04:10 PM Eastern Add Compare Share Share Ownership Stock AnalysisChartHoldingsOwnershipRatings Institutional Ownership Changes (13F Filings) for Amplify Weight Loss Drug & Treatment ETF (NYSEARCA:THNR)Number ofInstitutional Buyers(last 12 months)3TotalInstitutional Inflows(last 12 months)$730.60KNumber ofInstitutional Sellers(last 12 months)2TotalInstitutional Outflows(last 12 months)$238.70K Get THNR Insider Trade Alerts Want to know when executives and insiders are buying or selling Amplify Weight Loss Drug & Treatment ETF stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data THNR Institutional Buying and Selling by Quarter Amplify Weight Loss Drug & Treatment ETF Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/18/2025 GTS Securities LLC24,867$561K0.0%+95.2%0.000% 2/14/2025 Jane Street Group LLC23,676$534K0.0%+62.7%0.000% 2/10/2025 Harbour Investments Inc.6,888$155K0.0%-28.0%0.000% 11/15/2024 Jane Street Group LLC14,553$390K0.0%-31.4%0.000% 11/5/2024 Harbour Investments Inc.9,563$256K0.0%+43.4%0.000% 7/26/2024 Harbour Investments Inc.6,668$174K0.0%N/A0.000% (Data available from 1/1/2016 forward) THNR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of THNR shares? During the previous two years, the following institutional investors and hedge funds held shares of Amplify Weight Loss Drug & Treatment ETF shares: GTS Securities LLC ($561K), and Jane Street Group LLC ($534K), Harbour Investments Inc. ($155K).Learn more on THNR's institutional investors. Which institutional investors have been buying Amplify Weight Loss Drug & Treatment ETF stock? The following institutional investors have purchased Amplify Weight Loss Drug & Treatment ETF stock in the last 24 months: GTS Securities LLC ($12.13K), Harbour Investments Inc. ($9.56K), and Jane Street Group LLC ($9.12K). How much institutional buying is happening at Amplify Weight Loss Drug & Treatment ETF? Institutional investors have bought a total of 30,813 shares in the last 24 months. This purchase volume represents approximately $730.60K in transactions. Which Amplify Weight Loss Drug & Treatment ETF major shareholders have been selling company stock? The following institutional investors have sold Amplify Weight Loss Drug & Treatment ETF stock in the last 24 months: Jane Street Group LLC ($6.66K), and Harbour Investments Inc. ($2.68K). How much institutional selling is happening at Amplify Weight Loss Drug & Treatment ETF? Institutional investors have sold a total of 9,331 shares in the last 24 months. This volume of shares sold represents approximately $238.70K in transactions. Related Companies First Trust Indxx Metaverse ETF Institutional Ownership Xtrackers US Green Infrastructure Select Equity ETF Institutional Ownership iShares Neuroscience and Healthcare ETF Institutional Ownership AGF Global Infrastructure ETF Institutional Ownership AdvisorShares Restaurant ETF Institutional Ownership Harbor Corporate Culture Leaders ETF Institutional Ownership ProShares Decline of the Retail Store ETF Institutional Ownership Global X Disruptive Materials ETF Institutional Ownership Cboe Vest 10 Year Interest Rate Hedge ETF Institutional Ownership NYLI Clean Oceans ETF Institutional Ownership This page (NYSEARCA:THNR) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredGrab This Altcoin Before Trump's Crypto AnnouncementGrab This Altcoin Before Trump's Crypto Announcement Whatever it is, I expect it to pump the market, which ...Crypto 101 Media | SponsoredWe recommended Palantir in 2021, now we’re recommending this...I believe it could offer you a MAJOR boost to your retirement. And it pays huge dividends to give you a nic...Behind the Markets | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Amplify Weight Loss Drug & Treatment ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share Amplify Weight Loss Drug & Treatment ETF With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free THNR Stock Alerts